EUVIMEDEUVIMED entdecken
Editorial

Time for New Zealand to ban direct-to-consumer advertising of prescription medicines

David B Menkes, Barbara Mintzes, Joel Lexchin

New Zealand Medical Journal · 2023

DOI: 10.26635/6965.e1575 ↗

Kurz gefasst

Editorial in der Zeitschrift New Zealand Medical Journal, 2023. Verfasst von David B Menkes und 2 weiteren Autor:innen. Beteiligte Einrichtung: The University of Auckland, Waikato Clinical Campus, Hamilton. Hauptthemen laut MEDLINE: Direct-to-Consumer Advertising, Prescription Drugs. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Direct-to-Consumer AdvertisingPrescription DrugsHumansAdvertisingNew ZealandDrug IndustryPrescriptions

Substanzen

Prescription Drugs

Autor:innen und Institutionen

  • The University of Auckland, Waikato Clinical Campus, Hamilton.
  • The University of Sydney.
  • York University, Toronto.

Zitieren

APA

Menkes, D. B., Mintzes, B., & Lexchin, J. (2023). Time for New Zealand to ban direct-to-consumer advertising of prescription medicines. New Zealand Medical Journal. https://doi.org/10.26635/6965.e1575

Vancouver

Menkes DB, Mintzes B, Lexchin J. Time for New Zealand to ban direct-to-consumer advertising of prescription medicines. New Zealand Medical Journal. 2023. doi:10.26635/6965.e1575

BibTeX
@article{Menkes2023,
  author = {Menkes, David B and Mintzes, Barbara and Lexchin, Joel},
  title = {Time for New Zealand to ban direct-to-consumer advertising of prescription medicines},
  journal = {New Zealand Medical Journal},
  year = {2023},
  doi = {10.26635/6965.e1575}
}
Kostenlos starten →